SEC Form 4 · accession 0001615774-16-004872
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J Follman
Director · 10% Owner
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 9:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 5, 2016 | A | 250,000 | $0.00 | A | 6,741,310 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares are held in the Declaration of Trust of Robert J. Follman and Carole A. Follman, dated August 14, 1979 of which Mr. Follman is a trustee.